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FIGURE 3. lmmunohistochemistry of the tumor. Glial ftbrillary 
acidic protein is demonstrated only weakly and partially. (lm- 
munoperoxidase stain; magnification x.550.) 
The microscopic features of myxopapillary ependymoma 
are distinctive: papillary or reticular pattern of growth of the 
tumor cells and an abundant mutinous stroma. The present 
tumor showed these characteristic features on the hematoxylin- 
eosin-stained sections, so distinction from other cerebral tu- 
mors was not difficult. Blepharoplasts were not clemonstr-ated 
even by phosphotungstic acid-hematoxylin stain, but it is url- 
common to find them.’ Immunohistochemically, this variant 
usually shows a strongly positive reaction with GFAP. The 
present tumor, however, exhibited only weak and sporadic 
positivity with GFAP, whereas vimentin was expressed intensely 
and throughout the tumor. This phenomenon may indicate 
that, despite the fairly characteristic and benign appearance, 
this tumor is functionally undifferentiated.” 
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PROGESTERONE RECEPTORS IN BILATERAL OVARIAN EPENDYMOMA PRESENTING IN PREGNANCY 
KYLE A. CARR, MD, JAMES A. ROBERTS, MD, AND THOMAS S. FRANK, MD 
We present a case of a 25-year-old patient at term pregnancy who 
presented with a bilateral ovarian neoplasm that was histologically 
and immunohistochemically indistinguishable from ependymoma of 
the central nervous system. Progesterone receptors were detected in 
primary and recurrent neoplasms by immunohistochemistr. This is 
the first case of this rare neoplasm to present during pregnancy as 
well as with bilateral ovarian involvement. Together with a previ- 
ously reported case of recurrent ovarian ependymoma with estrogen 
and progesterone receptors, this case suggests that hormonal respon- 
siveness of this rare neoplasm may be pathogenically significant. 
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In 1982 Aguirre and Scully reported five cases of malig- 
nant ovarian tumors composed primarily of neuroectodermal 
tissue.’ Two of their cases contained distinct foci of ependymal 
tissue. Kleinman et al subsequently reported three cases of 
unilateral ovarian tumors composed purely of fully differen- 
tiated ependymal tissue.’ One of these cases recurred while 
the patient was receiving postoophorectomy estrogen and 
progestin replacement therapy, and cytosolic assay of the re- 
current tumor was positive for both estrogen and progesterone 
receptors.' We report a case of a bilateral ovarian ependymoma 
with peritoneal spread, discovered incidentally at cesarean 
section, that stained positively for progestin receptors in both 
the primary and recurrent neoplasms. 
CLINICAL HISTORY 
The patient was a 25-year-old woman (gravida II, para 
1001) at term, with a transverse lie requiring cesarean section. 
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CASE STUDIES 
Her past obstetric, gynecologic, and general medical histories 
were unremarkable. At the time of operation she was found 
to have an ovarian tumor that was biopsied and reported as 
malignant. Three weeks later, at the University of Michigan 
Medical Center, the patient underwent a staging laparotomy 
that included a total abdominal hysterectomy, bilateral sal- 
pingo-oophorectomy, omentectomy, resection of the right 
diaphragm and upper right lobe of the liver, and ultrasonic 
aspiration of all the tumor implants larger than 1 cm. The 
operative findings included 2 to 3 L of clear ascitic fluid, a 
20 X 20 cm right ovary, an 8 X 16 cm left ovary, diffuse 
involvement by tumor of most peritoneal surfaces, and a 20- 
cm mass involving the right liver lobe and the diaphragm. At 
completion of this surgery, no tumor implant larger than 1 
cm remained. The tumor was considered to be stage IV due 
to the liver involvement. 
The postoperative course was complicated by difficulty 
with pain control, a pneumothorax, a coagulopathy, and an 
episode of sepsis, all of which were successfully treated with 
medical management. The first course of chemotherapy was 
started on the 15th postoperative day, and the patient was 
discharged home on the 17th postoperative day. 
She was given six courses of BEP chemotherapy (100 mg/ 
m’ cisplatin and 100 mg/m’ etoposide plus an infusion of 15 
U/d bleomycin on days 1 to 3), which was tolerated without 
complications, with the exception of a right subclavian vein 
thrombosis. Four weeks after receiving six courses of che- 
motherapy the patient underwent a second look laparotomy. 
Multiple, I- to 4-mm implants of tumor were found throughout 
the peritoneal cavity and were biopsied. The patient experi- 
enced some bleeding from the dissection around the liver and 
developed a postoperative fever that responded to antibiotics. 
She was discharged home on the eighth postoperative day. 
Due to the presence of the small residual disease, the 
patient was treated with whole abdominal radiation. She tol- 
erated a dose of 2,560 centigray (cCy) to the abdomen, with 
kidney blocks placed at 1,760 cGy and liver blocks placed at 
2,060 cGy. The pelvis was boosted to a total dose of 4,472 
cGy. This treatment was well tolerated, with only nausea and 
vomiting complicating the treatment. The patient is doing well 
approximately 1 year after the initial presentation (3 months 
after completing the radiation theranv). She did not receive 
replacement hormonal therapy at 
resection. 
any time after the initial 
MATERIALS AND METHODS 
Sections of neoplastic tissue were fixed in 10% neutral 
buffered formalin and were then paraffin embedded. Sections 
were cut to 4 pm and stained with hematoxylin-eosin and pe- 
riodic acid-Schiff. Additional 4-pm sections on t_-lysine-coated 
slides were used for immunohistochemical studies using an 
avidin-biotin-peroxidase technique with commercially available 
antibodies for glial fibrillary acidic protein (GFAP) (Dako, 
Carpinteria, CA; diluted 1: 1 ,OOO), high molecular weight ker- 
atin (K576, Dako, diluted 1:500), and low molecular weight 
keratin (Cam 5.2, Becton-Dickinson, Mountain View, CA; di- 
luted 1: 10). Immunohistochemical stains for progesterone and 
estrogen receptor proteins4 (Abbott, Chicago, IL; diluted 1: 
2) were performed using an alkaline phosphatase technique. 
PATHOLOGY 
The right and left ovaries measured 14 and 16 cm in 
greatest dimension, respectively, and each had a capsule 
marked by papillary excrescences. On cut section each was 
predominantly multicystic, with cyst diameters ranging from 
1 to 10 cm bilaterally (Fig 1). Papillary excrescences were 
grossly visible on the inner surfaces of many of the cysts. The 
uterus, cervix, and fallopian tubes had multiple serosal implants 
of 1 to 2 mm. Hepatic and splenic biopsy specimens consisted 
of thin-walled cysts less than 2 cm in diameter, as well as frag- 
ments of friable tan tissue. Histologically, all of the areas of 
neoplastic involvement were composed of sheets of uniform, 
spindled to columnar cells with pink cytoplasm and regular, 
round to ovoid nuclei. Occasional ciliated cells were present. 
In many foci round and tubular-shaped rosettes were formed 
by neoplastic cells (Fig 2). In addition, vascular pseudorosettes 
were present and consisted of thin-walled blood vessels sur- 
rounded by cells with antipodally arranged nuclei and radiating 
fibrillary processes that tapered toward the vascular lumen. 
Although occasional papillae were present, no psammoma 
bodies were identified. Mitotic figures were not identified. 
Vascular invasion and areas of necrosis were present in both 
ovarian neoplasms. No derivatives of other germ cell layers 
were identified. Subsequent biopsy specimens obtained at sec- 
ond-look laparotomy contained cells with identical histologic 
features in irregular nests surrounded by fibrous tissue. Rosette 
formation was infrequent in the recurrent neoplasm. Perito- 
FIGURE 1. Sections of multicystic 
left and right ovarian ependymo- 
mas (shown on left and right, re- 
spectively) with focal excres- 
cences on the surface and in the 
lining of some cysts. 
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FIGURE 2. Rosette formation by 
tumor cells. (Hematoxylin-eosin 
stain; magnification X400.) 
neal washings obtained at the time of second-look laparotomy 
were positive for neoplasm. Both primary and recurrent neo- 
plastic cells stained diffusely positive for GFAP (Fig 3), but 
not for low or high molecular weight cytokeratins. In addition, 
immunohistochemical stains for progesterone receptor showed 
areas of strong nuclear staining in both primary and recurrent 
neoplasms (Fig 4). No staining for estrogen receptor protein 
was seen. 
DISCUSSION 
‘I’his represents the fol 
moma of the ovary and the fi 
The ovaries in this case, at 
than previously reported (1 
viously reported cases of this 
with stage III disease and or 
urth reported case of an ependy- 
lrst case with bilateral involvement. 
14 and 16 cm in size, were larger 
.O to 13.0 cm).’ Of the three pre- 
rare entity, two patients presented 
le with stage I disease. The patient 
FIGURE 3. Glial fibrillary acidic 
protein in appendiceal implants 
of recurrent ovarian ependy- 
moma. (Immunohistochemical 
stain; magnification X200.) 
CASE STUDIES 
FIGURE 4. Positive staining for progesterone 
receptor in the nuclei of tumor cell nests was 
seen in recurrent (as well as primary) epen- 
dymoma. Note abortive rosette formation by 
the tumor cells. (Immunohistochemical stain; 
magnification X400.) 
with stage I presentation was alive with no evidence of disease 
5 years later. Of the two patients with stage III disease, one 
died of disease as originally reported. The other patient with 
advanced disease was subsequently re-reported when the tumor 
recurred 5 years later while she was receiving replacement 
estrogen and progestin replacement therapy.” The recurrent 
neoplasm was found to be positive for cytosolic estrogen and 
progesterone receptors, and after cessation of hormonal re- 
placement the patient has remained disease free. The case 
presented here is the first with bilateral ovarian involvement 
as well as the first to present as stage IV disease. The extent 
of this tumor at term pregnancy along with the finding of 
progesterone receptors in the neoplasm are very suggestive 
that the tumor’s growth was influenced by hormonal factors. 
This is not unique to those ependymomas that occur in the 
female genital tract; progesterone (and estrogen) receptors 
have been reported in ependymomas’ and other primary neo- 
plasms of the spinal cord6 and are thought to account for the 
rapid clinical course of some spinal cord tumors in the luteal 
phase of the menstrual cycle and during pregnancy.7 
The histologic feature that most facilitated the diagnosis 
in this case was the prominence of rosettes and perivascular 
pseudorosettes. With positive immunohistochemical staining 
for GFAP, this cellular pattern is quite characteristic of an 
ependymoma.’ Other histologic features of this case were 
consistent with those of the previously reported cases of ovar- 
ian ependymoma.’ Psammoma bodies were noted in two re- 
ported cases of ependymoma of the broad ligament,” but they 
were not identified in our case nor were they seen in the three 
cases of ovarian ependymoma originally reported. As reviewed 
in that report,’ the differential diagnosis of this neoplasm in- 
cludes serous and endometrioid tumors due to the presence 
of papillae. In fact, the biopsy specimens from this lesion were 
initially submitted with a diagnosis of papillary adenocarci- 
noma. However, the identification of the features described 
above, especially in conjunction with immunohistochemical 
stains for GFAP, ensures the correct diagnosis. 
The histogenic origin of extraspinal ependymomas may 
vary with location. Extramedullary ependymomas also have 
been reported in the subcutaneous tissue of the sacrococcygeal 
region, ” adjacent to the sacrum, ‘I and in the mediastinum.” 
In the sacrococcygeal region these tumors are thought to arise 
from heterotopic ependymal cell rests or from the coccygeal 
medullary vestige.‘03” Previous reports of ependymomas of 
the female genital tract include three cases in the ovary,’ two 
in the broad ligament,” and one in the mesovarium.” No 
ependymal islands, per se, are thought to exist in these loca- 
tions. Like other neuroectodermal tumors of the ovary, epen- 
dymal neoplasms arising in the ovary are believed to represent 
monodermal teratomas.’ In contrast, ependymomas of the 
broad ligament have been postulated to arise from neometa- 
plasia of mesenchymal cells.” The origin of ependymomas of 
mediastinum and mesovarium is unclear.‘23’3 
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